Macular Degeneration - McKnight's Long Term Care News

Macular Degeneration

Clinical Briefs for Thursday, January 23

Use of opioids a balancing act when treating pain in residents with Alzheimer’s … GSK halts  nationwide production of 2 Excedrin drugs … Drug combo reverses arthritis in rats … Discovery may lead to simplified treatment for blinding macular degeneration

Clinical Briefs for Wednesday, December 18

Simple tool predicts life expectancy after dementia diagnosis … FDA approves first triglyceride drug, a complement to statin therapy … Older women top list of those who take weekly sleep meds … NIH launches first trial of therapy for age-related eye disease

Clinical Briefs for Monday, July 29

Experts call for large-scale macular degeneration research … Genetic risk not a factor in dietary interventions for type 2 diabetes … Older adults are not meeting HHS activity guidelines … Clues in brain’s waste system may help explain Alzheimer’s

FDA approves new macular degeneration treatment

The Food and Drug Administration has approved a new drug for the treatment of the wet form of age-related macular degeneration, called Eylea. Macular degeneration is the leading cause of severe vision loss in the elderly.

Next post in News